%0 Journal Article
%T Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
%A A. Jorsal
%A C. D. A. Stehouwer
%A C. G. Schalkwijk
%A H.-H. Parving
%A J. Buijs
%A L. Engelen
%A L. Tarnow
%A P. Rossing
%A S. A. Peeters
%J Archive of "Cardiovascular Diabetology".
%D 2017
%R 10.1186/s12933-017-0539-1
%X Altered regulation of extracellular matrix remodeling by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) may contribute to vascular complications in type 1 diabetes. We investigated associations between plasma MMP-1, -2, -3, -9, -10 and TIMP-1, and cardiovascular events and all-cause mortality in type 1 diabetic patients
%K Type 1 diabetes
%K Cardiovascular disease
%K All-cause mortality
%K Matrix metalloproteinase
%K Tissue inhibitor of metalloproteinase
%K Estimated glomerular filtration rate
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405549/